Somatosensory Phenotyping of ADPKD
A legfontosabb adatok
- Hol
- Leuven (Belgium)A helyszín megnézése
AI-kivonat: kiket keres a vizsgálat
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
A vizsgálat 12 éves vagy idősebb ADPKD-s betegeket keres, valamint hasonló korú, nemű és testtömegindexű egészséges önkénteseket az összehasonlításhoz. Fájdalomérzékenységi vizsgálatot végeznek, és kérdőíveket töltenek ki.
- Életkor
- 12 év vagy idősebb
- Nem
- Minden nemű személy részt vehet.
- A betegség stádiuma
- A betegeknél ADPKD-t kell diagnosztizálni. Az egészséges önkénteseknek általában jó egészségi állapotban kell lenniük.
- Korábbi kezelés
- A betegek nem lehetnek jelenleg dialízisen, nem lehet veseátültetésük, és nem szedhetnek tolvaptant. A vizsgálat eredményét zavaró, közelmúltban szedett gyógyszerek vagy kezelések nem megengedettek.
A részvétel fő kizáró okai
- Bőrproblémák (például ekcéma vagy pikkelysömör) a domináns kézen vagy az alsó háton, amelyek zavarhatják a vizsgálatokat
- Terhes vagy szoptató nők
- Rendszeres kannabisz- vagy tiltott drogfogyasztás, illetve drogabúzus a kórtörténetben
- Alkoholfogyasztás minden vizit előtti 24 órában, vagy napi 3 vagy több alkoholos ital
- Egyidejű részvétel másik vizsgálatban
Gépi kiolvasás: 2026. november 9.
Helyszínek itt: Belgium
- UZ LeuvenLeuven, BelgiumRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Universitaire Ziekenhuizen KU Leuven
- Azonosító
- NCT06970028
- A regiszteradat frissítve
- 2025. november 17.
- Eredeti leírás
Over 60% of patients with ADPKD suffer from pain, mostly in the abdomen, flank and back, often leading to the diagnosis. It is challenging to manage and cure the pain; approximately 39% of patients are not satisfied with their pain treatment, since the pain prevents them from doing various activities, affecting their quality of life. Pain can be present before enlargement of the kidneys, the source of the pain is often unknown and common analgesics are insufficient to manage the pain or cannot be taken due to renal impairment. By further investigating and characterizing the pain phenotype of the ADPKD population, pain management might be improved and alternative therapeutic approaches might be developed. In this clinical study, pain will be assessed in patients with ADPKD using Quantitative Sensory Testing (QST) on the dominant hand and the lower back, together with four questionnaires regarding pain and quality of life. These results will be compared with the somatosensory profile of matched healthy volunteers.A teljes eredeti leírásKevesebb
Somatosensory Phenotyping of Patients With ADPKD Using Quantitative Sensory Testing and Questionnaires
Over 60% of patients with ADPKD suffer from pain, mostly in the abdomen, flank and back, often leading to the diagnosis. It is challenging to manage and cure the pain; approximately 39% of patients are not satisfied with their pain treatment, since the pain prevents them from doing various activities, affecting their quality of life. Pain can be present before enlargement of the kidneys, the source of the pain is often unknown and common analgesics are insufficient to manage the pain or cannot be taken due to renal impairment. By further investigating and characterizing the pain phenotype of the ADPKD population, pain management might be improved and alternative therapeutic approaches might be developed. In this clinical study, pain will be assessed in patients with ADPKD using Quantitative Sensory Testing (QST) on the dominant hand and the lower back, together with four questionnaires regarding pain and quality of life. These results will be compared with the somatosensory profile of matched healthy volunteers.
Bevonási feltételek: Patients with ADPKD; Subject is ≥ 12 years old; Subject is diagnosed with ADPKD; Healthy volunteers; Subject is ≥ 12 years old; Subject is in good general health, based on medical history and vital signs; Subject is matched to the patient group for age, sex and BMI.
Kizáró feltételek: Subject is currently undergoing dialysis, had a kidney transplant or is a user of tolvaptan; Subject is unable to refrain from drinking alcohol 24 hours prior to each study visit, and/or consumes ≥ 3 alcoholic consumptions per day; Subject is unable to refrain from drinking caffeinated beverages (such as coffee, tea, cola,…) 24 hours prior to each study visit; Subject has used concomitant drugs and/or treatments in a period smaller than or equal to 5 half-lives prior to enrollment, that may interfere, in the investigator's opinion, with the study results; Subject is unable to refrain from drinking alcohol 24 hours prior to each study visit, and/or consumes ≥ 3 alcoholic consumptions per day; Subject is unable to refrain from drinking caffeinated beverages (such as coffee, tea, cola,…) 24 hours prior to each study visit; Subject has used concomitant drugs and/or treatments in a period smaller than or equal to 5 half-lives prior to enrollment, that may interfere, in the investigator's opinion, with the study results; Subject is a regular user of cannabis, any illicit drugs and/or has a history of drug abuse; Subject has a history of any illness or condition which, in the investigator's opinion, may interfere with safe and optimal participation in the study; Healthy volunteers; Subject has a history of any illness or condition which may affect the normal somatosensory functionality; Subject is a regular user of cannabis, any illicit drugs and/or has a history of drug abuse; Subject has a history of any illness or condition which, in the investigator's opinion, may interfere with safe and optimal participation in the study; Patients with ADPKD; Subject has eczema, scleroderma, psoriasis, dermatitis, or any other abnormality on the skin of the dominant hand and/or lower back which, in the investigator's opinion, might interfere with the study assessments; Female who is pregnant or breastfeeding; Simultaneous participation in another study which, in the investigator's opinion, might confound the results of the study; Subject has eczema, scleroderma, psoriasis, dermatitis, or any other abnormality on the skin of the dominant hand and/or lower back which, in the investigator's opinion, might interfere with the study assessments; Female who is pregnant or breast-feeding; Simultaneous participation in another study which, in the investigator's opinion, might confound the results of the study.